Atlas Trials

A Study to Evaluate Efficacy, Safety and Tolerability of Hydroxychloroquine in Subjects With Parkinson's Disease

Clinical trial NCT06816810 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06816810
Sponsor
Ottawa Hospital Research Institute
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson&Amp;#39;s Disease
Start date
2025-03-01
Primary completion
2026-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.